Sarepta Therapeutics Inc (SRPT)
117.09
+0.23
(+0.20%)
USD |
NASDAQ |
Apr 23, 16:00
117.09
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Revenue (TTM): 1.243B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.243B |
| September 30, 2023 | 1.105B |
| June 30, 2023 | 1.003B |
| March 31, 2023 | 975.68M |
| December 31, 2022 | 933.01M |
| September 30, 2022 | 876.05M |
| June 30, 2022 | 835.18M |
| March 31, 2022 | 765.79M |
| December 31, 2021 | 701.89M |
| September 30, 2021 | 645.56M |
| June 30, 2021 | 600.08M |
| March 31, 2021 | 573.36M |
| December 31, 2020 | 540.10M |
| September 30, 2020 | 495.07M |
| June 30, 2020 | 450.19M |
| March 31, 2020 | 407.50M |
| December 31, 2019 | 380.83M |
| September 30, 2019 | 365.14M |
| June 30, 2019 | 344.58M |
| March 31, 2019 | 323.44M |
| December 31, 2018 | 301.03M |
| September 30, 2018 | 273.90M |
| June 30, 2018 | 241.36M |
| March 31, 2018 | 202.85M |
| December 31, 2017 | 154.58M |
| Date | Value |
|---|---|
| September 30, 2017 | 102.73M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 9.757M |
| September 30, 2014 | 12.36M |
| June 30, 2014 | 15.46M |
| March 31, 2014 | 15.83M |
| December 31, 2013 | 14.22M |
| September 30, 2013 | 18.93M |
| June 30, 2013 | 22.34M |
| March 31, 2013 | 30.59M |
| December 31, 2012 | 37.33M |
| September 30, 2012 | 43.58M |
| June 30, 2012 | 43.53M |
| March 31, 2012 | 43.91M |
| December 31, 2011 | 46.99M |
| September 30, 2011 | 48.92M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
344.58M
Minimum
Jun 2019
1.243B
Maximum
Dec 2023
696.93M
Average
645.56M
Median
Sep 2021
Revenue (TTM) Benchmarks
| PTC Therapeutics Inc | 937.82M |
| Vertex Pharmaceuticals Inc | 9.869B |
| Regenxbio Inc | 90.24M |
| CytomX Therapeutics Inc | 101.21M |
| Apellis Pharmaceuticals Inc | 396.59M |